Equity
€101,524 ▼ 3.7%
Audrey Bonnelance paid out €65,000 in dividends. That is 106% of the 2025 profit.
Audrey Bonnelance
Lifetime
10 annual accounts with figures on one time axisGross marginpeak €82,089 (2025)
€82,089▲ 43.7%
Resultpeak €61,150 (2025)
€61,150▲ 50.1%
Equitypeak €157,211 (2021)
€101,524▼ 3.7%
Debts
€4,529▼ 90.2%
Board1 name since 2021
1 directorAudrey Bonnelance
Documentsfilings and deeds
18-06-202643 days before the deadline
2025micro format
Gross margin from €57,110 to €82,089Result from €40,738 to €61,150Dividend €65,000Debts from €46,426 to €4,529Cash from €101,266 to €48,676
Key points
from the 2025 annual accountsLiquidity
20.75 was 3.29 in 2024
Short-term debts fell from €41,682 to €4,529.
Position in the sector
95.7%
Higher solvency than 92% of companies in human health. Sector median 63.0% · 20,736 companies.
Checked score
97
Excellent
Financially stronger than 72% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,173 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025lowest value
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 20.75, cash €48,676, halved
Equity €101,524 (95.7% of total assets)
Size: total assets €106,053
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 80% on profitability and 31% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 34,693 companies had the same profile as Audrey Bonnelance has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of Audrey Bonnelance itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,693 companies, not a prediction for Audrey Bonnelance. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 20.75 (3.29 in 2024), above the usual 1.5. Short-term debt is 4.3% and cash 45.9% of total assets. 4.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
43 days early
2024
on the day
2023
63 days early
2022
69 days early
2021
3 days early
2020
11 days early
2019
19 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 24 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 June (4 of the last 5 accounts filed within 40 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- BONNELANCE Audrey Christine Perrine 99 sharesdeed of 06-12-2021
- HAERTEN Florence Jean Marie 1 sharedeed of 06-12-2021
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0647865968
Change of role: BONNELANCE Audrey Christine Perrine, from manager to director
Director discharge: BONNELANCE Audrey Christine Perrine · BONNELANCE Audrey Christine Perrine holds 99 shares · HAERTEN Florence Jean Marie holds 1 share · General meeting of 23-11-2021 · Gazette deed
Incorporation
published on 09-02-2016 · Gazette deed
First establishment
Patriottenstraat 52, Brussels
Comparable companies
same main activity, similar in size and age| Company | Total assets | Gross margin | Solvency | Staff |
|---|---|---|---|---|
| Audrey Bonnelance Woluwe-Saint-Pierre | €106,053 | €82,089 | 95.7% | - |
| ESSEA MEDIC Grez-Doiceau | €109,932 | €78,944 | 16.9% | - |
| Docteur Sophie VANDENDAEL Chaudfontaine | €114,453 | €82,686 | 23.3% | - |
| Denis JARBINET Nandrin | €113,586 | €76,060 | 29.2% | - |
| DR. ISABELLE MARTIN Aywaille | €109,839 | €93,344 | 33.9% | - |
| MARGIVAL Woluwe-Saint-Pierre | €92,792 | €89,171 | 81.6% | - |
| Velasco MB Cabinet Médical Ixelles | €97,473 | €76,201 | 47.2% | - |
These companies have the same main activity as Audrey Bonnelance: general medical practice (NACE 86210). They are comparable in size and age: total assets between €92,800 and €114,000, founded between 2014 and 2018.
Official details
Source: KBO- Status
- Active since 05-02-2016Normal situation
- Activity
- General medical practiceNACE 86210and 2 others
- Establishment unit
- 2.249.971.3191000 Brussels, since 05-02-2016
- Financial year end
- 31 December
- Peppol
- Reachable since 11-06-2025
Annual accounts 2025
- Turnover
- ≈ €180,000estimated
- Total assets
- €106,053▼ 30.1%
- Filing
- Filed on 18-06-2026, 43 days before the end of the filing period
Insights on Audrey Bonnelance
Audrey Bonnelance files the micro format. That format states no turnover. The gross margin rose from €10,337 in 2016 to €82,089 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Audrey Bonnelance
- What is the company number of Audrey Bonnelance?
- The company number of Audrey Bonnelance is 0647.865.968. The VAT number is the same number with BE in front: BE 0647.865.968.
- Where is Audrey Bonnelance based?
- The registered office is at Luchtvaartlaan 81, 1150 Woluwe-Saint-Pierre.Company details
- What does Audrey Bonnelance do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Audrey Bonnelance?
- Audrey Bonnelance is a private limited company (BV).
- When was Audrey Bonnelance founded?
- Audrey Bonnelance was founded on 05-02-2016.
- Is Audrey Bonnelance still active?
- Yes, Audrey Bonnelance is an active enterprise in the KBO register.
- What is the turnover of Audrey Bonnelance?
- The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €82,089 and 32 comparable companies (NACE 862). It probably lies between €140,000 and €240,000.Financials
- Is Audrey Bonnelance profitable?
- In financial year 2025, Audrey Bonnelance made a profit of €61,150.
- Where can I find the annual accounts of Audrey Bonnelance?
- Audrey Bonnelance filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Audrey Bonnelance due?
- Audrey Bonnelance must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.